glp 1 receptor antagonist drugs Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide Agonists: A Scoping Review List of approved and pending
Description
Associations of concurrent hypertension and type 2 diabetes with mortality outcomes: a prospective study of U.S
Koegler, F
The identification and confirmation of a highly effective, balanced dual incretin agonist enables a more physiological approach to treating conditions associated with impaired glucose tolerance [78]
Treatments must align with metabolic physiology, behavioural science, and sustainable lifestyle adjustments to achieve real, lasting results
doi: 10.2337/db10-0103 [DOI] [PMC free article] [PubMed] [Google Scholar] 66
Samples were genotyped at the Affymetrix Research Services Laboratory in Santa Clara, California, USA
